GRP94/gp96 elicits ERK activation in murine macrophages -: A role for endotoxin contamination in NF-κB activation and nitric oxide production

被引:82
作者
Reed, RC [1 ]
Berwin, B [1 ]
Baker, JP [1 ]
Nicchitta, CV [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
关键词
D O I
10.1074/jbc.M305480200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vaccination of mice with GRP94/gp96, the endoplasmic reticulum Hsp90, elicits a variety of immune responses sufficient for tumor rejection and the suppression of metastatic tumor progression. Macrophages are a prominent GRP94/gp96 target, with GRP94/gp96 reported to activate macrophage NF-kappaB signaling and nitric oxide production, as well as the MAP kinase p38, JNK, and ERK signaling cascades. However, recent studies report that heat shock protein elicited macrophage activation is due, in large part, to contaminating endotoxin. To examine the generality of this finding, we have investigated the role of endotoxin in GRP94/gp96 elicited macrophage activation. We report that GRP94/ gp96 binds endotoxin in a high-affinity, saturable, and specific manner. Low endotoxin calreticulin and GRP94/ gp96 were purified, the latter using a novel method of depyrogenation; this resulted in GRP94/ gp96 and calreticulin preparations with endotoxin levels substantially lower than those of previously reported preparations. Low endotoxin GRP94/ gp96 retained its native conformation, ligand binding activity, and in vitro chaperone function, yet did not activate macrophage NF-kappaB signaling, nitric oxide production or inducible nitric-oxide synthase production. Low endotoxin GRP94/ gp96 and calreticulin did, however, elicit a marked increase in ERK phosphorylation at protein concentrations as low as 2 mug/ml. These results are discussed with respect to current understanding of the contributions of endotoxin and heat shock/chaperone proteins to the stimulation of innate immune responses.
引用
收藏
页码:31853 / 31860
页数:8
相关论文
共 60 条
  • [1] Antón LC, 1998, J IMMUNOL, V160, P4859
  • [2] Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4
    Asea, A
    Rehli, M
    Kabingu, E
    Boch, JA
    Baré, O
    Auron, PE
    Stevenson, MA
    Calderwood, SK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) : 15028 - 15034
  • [3] HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
    Asea, A
    Kraeft, SK
    Kurt-Jones, EA
    Stevenson, MA
    Chen, LB
    Finberg, RW
    Koo, GC
    Calderwood, SK
    [J]. NATURE MEDICINE, 2000, 6 (04) : 435 - 442
  • [4] GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression
    Baker-LePain, JC
    Sarzotti, M
    Fields, TA
    Li, CY
    Nicchitta, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) : 1447 - 1459
  • [5] Barouch R, 2001, J LEUKOCYTE BIOL, V69, P1019
  • [6] Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
    Basu, S
    Binder, RJ
    Suto, R
    Anderson, KM
    Srivastava, PK
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) : 1539 - 1546
  • [7] Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity
    Basu, S
    Srivastava, PK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 797 - 802
  • [8] Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
  • [9] 2-C
  • [10] Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings
    Belli, F
    Testori, A
    Rivoltini, L
    Maio, M
    Andreola, G
    Sertoli, MR
    Gallino, G
    Piris, A
    Cattelan, A
    Lazzari, I
    Carrabba, M
    Scita, G
    Santantonio, C
    Pilla, L
    Tragni, G
    Lombardo, C
    Arienti, F
    Marchianò, A
    Queirolo, P
    Bertolini, F
    Cova, A
    Lamaj, E
    Ascani, L
    Camerini, R
    Corsi, M
    Cascinelli, N
    Lewis, JJ
    Srivastava, P
    Parmiani, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4169 - 4180